Form 4: RxSight Director Juliet Tammenoms Bakker Acquires 5,000 Shares
SEC Form 4 Filing
Director Juliet Tammenoms Bakker purchased 5,000 shares of RxSight, Inc. at $61.0913 per share on May 17, 2024.
Summary
- On May 17, 2024, Juliet Tammenoms Bakker, a director of RxSight, Inc., acquired 5,000 shares of common stock at a price of $61.0913 per share.
- Following this transaction, Ms. Bakker directly owns 34,840 shares of RxSight, Inc.
- Ms. Bakker also indirectly owns 1,548 shares through a trust where she serves as the Investment Trustee.
- She disclaims beneficial ownership of these indirectly held shares except to the extent of her pecuniary interest.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares can be seen as a positive sign, but it's a single transaction and doesn't provide definitive insight into the company's overall health.
Positives
- The director's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Insider transactions are closely monitored as they can provide insights into a company's performance and future expectations. This purchase by a director may be viewed positively by investors.
Stakeholder Impact
- The purchase may positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/17/2024 | Date of the transaction where Juliet Tammenoms Bakker acquired 5,000 shares of RxSight, Inc. |
| 05/21/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.